Laboratorio Farmaceutico Erfo Dividends and Buybacks
Dividend criteria checks 3/6
Laboratorio Farmaceutico Erfo is a dividend paying company with a current yield of 6.52%.
Key information
6.5%
Dividend yield
6.5%
Buyback Yield
| Total Shareholder Yield | 13.0% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.060 |
| Payout ratio | 116% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether RK7's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if RK7's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| Laboratorio Farmaceutico Erfo Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RK7) | 6.5% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Personal Products) | 2.3% |
| Analyst forecast (RK7) (up to 3 years) | n/a |
Notable Dividend: RK7's dividend (6.52%) is higher than the bottom 25% of dividend payers in the German market (1.74%).
High Dividend: RK7's dividend (6.52%) is in the top 25% of dividend payers in the German market (4.76%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (116.1%), RK7's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (53.2%), RK7's dividend payments are covered by cash flows.